scispace - formally typeset
R

Ranganathan N Iyer

Researcher at Global Hospitals Group

Publications -  25
Citations -  517

Ranganathan N Iyer is an academic researcher from Global Hospitals Group. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 6, co-authored 20 publications receiving 399 citations.

Papers
More filters
Journal ArticleDOI

Incidence, characteristics and outcome of ICU-acquired candidemia in India

TL;DR: A high burden of candidemia in Indian ICUs, early onset after ICU admission, higher risk despite less severe physiology score at admission and a vast spectrum of agents causing the disease with predominance of C. tropicalis is highlighted.
Journal Article

Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data).

TL;DR: The study showed a high incidence of ESBL-producers amongst Enterobacteriaceae isolates from intra-abdominal infections in both community-acquired and hospital-acquire settings across India.
Journal ArticleDOI

Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia

TL;DR: The objective of this study was to develop a specific score to predict mortality in solid organ transplant recipients with carbapenemase‐producing Enterobacterales bloodstream infections with a stratified analysis of the effect of monotherapy vs combination therapy.
Journal ArticleDOI

Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and Paratyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study.

TL;DR: The study findings support the use of third-generation cephalosporins and azithromycin as first-line therapy and ampicillin and co-trimoxazole as step-down therapy in pediatric enteric fever, however, continued local surveillance should be done to detect antimicrobial resistance trends to optimize treatment.